Antibiotic | Antibiotic-susceptibility profile | ||||
---|---|---|---|---|---|
Sensitive n (%) | Intermediate n (%) | Resistant n (%) | Not determined n (%) | Resistance rates (%) | |
Ceftazidime | 62 (78.5) | 7 (8.9) | 10 (12.7) | – | 21.5 |
Trimethoprim + Sulfamethoxazole | 72 (91.1) | 6 (7.6) | 1 (1.3) | – | 8.8 |
Piperacillin + Tazobactam | 59 (74.7) | 13 (16.5) | 5 (6.3) | 2 (2.5) | 22.8 |
Imipenem | 66 (83.5) | 5 (6.3) | 8 (10.1) | – | 16.5 |
Ciprofloxacin | 10 (12.7) | 22 (37.8) | 47 (59.5) | – | 87.3 |
Ticarcillin+ Clavulanic acid | 58 (73.4) | 6 (7.6) | 5 (6.3) | 10 (12.7) | 13.9 |